Why do investors love biotech stocks? Because these players often work on game-changing technology that could lead to tomorrow's game-changing treatment -- and potentially blockbuster revenue. As an investor, you often have to be patient, as it takes years for a company to bring a candidate through development and reach the billion-dollar revenue stage. And you have to be comfortable with a bit of risk too, because candidate failure always is a possibility.

But, if you choose quality companies with strong pipelines and at least one of their potential products succeeds, you could be in for significant gains over time. And today, with just $200, you can get in on three companies that have reached the finish line or are approaching it and have what it takes to soar over the long run. Let's check out these three no-brainer biotech buys.

Image source: Getty Images.

Continue reading

Source Fool.com